NCT01511094

Brief Summary

The study has the purpose to evaluate the effectiveness and safety of the goniocurettage as a first choice of surgical treatment for primary open-angle glaucoma (POAG) in patients with good vision.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
32

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Jun 2009

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2009

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2010

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

October 14, 2011

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2012

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 18, 2012

Completed
Last Updated

January 18, 2012

Status Verified

January 1, 2012

Enrollment Period

11 months

First QC Date

October 14, 2011

Last Update Submit

January 17, 2012

Conditions

Keywords

ab-interno trabeculectomy,intraocular pressure,open angle glaucomatrabeculectomyGoniocurettageNon-Filtering Surgery

Outcome Measures

Primary Outcomes (1)

  • Intra Ocular Pressure

    The mean of at least three measures at 8:00 am two weeks before surgery. After intervention, the Intra Ocular Pressure was measured on the day after, one week after, two weeks after and every month at the same time until the end of the study (an expected average of 20 months).

    Change from Baseline in Intra Ocular Pressure at 20 months

Secondary Outcomes (3)

  • Central Corneal Thickness

    Two weeks before, six months after and one year after intervention

  • Central corneal endothelial cell density

    Two weeks before, six months after intervention and one year after intervention

  • Best correct visual acuity

    Two weeks before, six months after and one year after intervention

Study Arms (1)

Eye Surgery

EXPERIMENTAL

Goniocurettage was used to treat open angle glaucoma patients

Procedure: Goniocurettage

Interventions

Ab interno surgery consisting on scraped away the trabecular tissue from the angle (goniocurettage) removing segments of pathologically altered trabecular meshwork from the scleral sulcus

Also known as: Ab interno glaucoma precedure, Open angle glacuoma surgery, Non filtering glaucoma procedure
Eye Surgery

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Disc and/or visual field findings consistent with Primary Open Angle Glaucoma
  • Uncontrolled intraocular pressure (≥21 mm Hg) or progressive glaucomatous neuropathy despite maximum tolerated medical therapy
  • years old or over
  • Visual acuity higher than 0.2
  • Open angles (greater or equal to Shaffer grade II)

You may not qualify if:

  • Previous ocular surgery
  • History of glaucoma laser treatment
  • History of ocular trauma
  • Cyclodestructive procedures
  • Corneal edema or opacities
  • Endothelial decompensation
  • History of uveitis
  • Secondary glaucoma
  • neovascularization of the iris or angle
  • Congenital anterior segment abnormalities
  • Anatomically confusing angles without clear definition of the scleral spur or meshwork and inability to maintain follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Federal University of Minas Gerais

Belo Horizonte, Minas Gerais, 30130-100, Brazil

Location

Related Publications (5)

  • Jacobi PC, Dietlein TS, Krieglstein GK. Technique of goniocurettage: a potential treatment for advanced chronic open angle glaucoma. Br J Ophthalmol. 1997 Apr;81(4):302-7. doi: 10.1136/bjo.81.4.302.

    PMID: 9215060BACKGROUND
  • Jacobi PC, Dietlein TS, Krieglstein GK. Goniocurettage for removing trabecular meshwork: clinical results of a new surgical technique in advanced chronic open-angle glaucoma. Am J Ophthalmol. 1999 May;127(5):505-10. doi: 10.1016/s0002-9394(98)00448-6.

    PMID: 10334341BACKGROUND
  • Jacobi PC, Dietlein TS, Krieglstein GK. Microendoscopic trabecular surgery in glaucoma management. Ophthalmology. 1999 Mar;106(3):538-44. doi: 10.1016/S0161-6420(99)90113-6.

    PMID: 10080211BACKGROUND
  • Johnson DH, Johnson M. How does nonpenetrating glaucoma surgery work? Aqueous outflow resistance and glaucoma surgery. J Glaucoma. 2001 Feb;10(1):55-67. doi: 10.1097/00061198-200102000-00011.

    PMID: 11219641BACKGROUND
  • Minckler D, Baerveldt G, Ramirez MA, Mosaed S, Wilson R, Shaarawy T, Zack B, Dustin L, Francis B. Clinical results with the Trabectome, a novel surgical device for treatment of open-angle glaucoma. Trans Am Ophthalmol Soc. 2006;104:40-50.

    PMID: 17471324BACKGROUND

MeSH Terms

Conditions

Glaucoma, Open-Angle

Condition Hierarchy (Ancestors)

GlaucomaOcular HypertensionEye Diseases

Study Officials

  • Tiago T Souza, MD

    Federal University of Minas Gerais

    PRINCIPAL INVESTIGATOR
  • Sebastiao Cronemberger, PhD

    Federal University of Minas Gerais

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 14, 2011

First Posted

January 18, 2012

Study Start

June 1, 2009

Primary Completion

May 1, 2010

Study Completion

January 1, 2012

Last Updated

January 18, 2012

Record last verified: 2012-01

Locations